Clinical Trials Browser

Phase 3 × OTHER × obinutuzumab × Clear all

NCT05929222 2025-12-24

FIL_GAZEBO

Phase 3 Recruiting

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT04608318 2024-12-31

CLL17

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT02950051 2024-12-30

GAIA

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06284122 2024-10-15

MorningLyte

Phase 3 Recruiting

Lymphoma, Follicular